3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
12
Breast Neoplasms
7
Neoplasm Metastasis
5
Lymphoma
5
Multiple Myeloma
4
Leukemia
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Prostatic Neoplasms
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Depression
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Ovarian Neoplasms
2
Motor Activity
2
Malignant Female Reproductive System Neoplasm
2
Glioblastoma
2
Fatigue
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Caregiver Burden
2
Anxiety Disorders
2
Advanced Malignant Solid Neoplasm
2
Thyroid Neoplasms
1
Stroke
1
Stress Disorders, Post-Traumatic
1
Squamous Cell Carcinoma of Head and Neck
1
Sleep Initiation and Maintenance Disorders
1
Signs and Symptoms
1
Interventions
Standard of Care
2
Rituximab
2
Carvedilol
2
sacubitril and valsartan sodium hydrate drug combination
1
pegfilgrastim
1
obinutuzumab
1
empagliflozin
1
dapagliflozin
1
acalabrutinib
1
Vincristine
1
Vascular Stiffness
1
Valsartan
1
Specimen Handling
1
Pulse Wave Analysis
1
Prednisolone
1
Practice Guidelines as Topic
1
Palliative Care
1
Nutrition Assessment
1
Mesenchymal Stem Cell Transplantation
1
Lenalidomide
1
Health Information Exchange
1
Exercise
1
Eplerenone
1
Electronic Health Records
1
Electrocardiography
1
Echocardiography
1
Doxorubicin
1
Dexrazoxane
1
Cyclophosphamide
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Heart Failure
×
Palliative Care
×
1 year
×
Clear all
NCT04598646
2025-12-03
HIMALAYAS-P
University Health Network, Toronto
Phase NA
Completed
30 enrolled